[
Baert, F. J., D’Haens, G. R., Peeters, M., Hiele, M. I., Schaible, T. F., Shealy, D., Geboes, K., Rutgeerts, P. J. (1999). Tumor necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn’s ileocolitis. Gastroenterology, 116 (1), 22–28.10.1016/S0016-5085(99)70224-6
]Search in Google Scholar
[
Best, W. R., Becktel, J. M., Singleton, J. W., Kern Jr., F. (1976). Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology, 70 (3), 439–444.10.1016/S0016-5085(76)80163-1
]Search in Google Scholar
[
Colombel, J., Rutgeerts, P., Sandborn, W. J. (2010). Deep remission for adalimumab-treated patients with moderate to severe ileocolonic Crohn’s disease: Results from EXTEND. J. Crohn’s Colitis, 4, S11. Abstract OP31.
]Search in Google Scholar
[
Colombel, J., Rutgeerts, P., Sandborn, W. J. (2010). Deep remission predicts long-term outcomes for adalimumab-treated patients with Crohn’s disease: Data from EXTEND. Gut, 59 (Suppl. 3), A80. Abstract OP371.
]Search in Google Scholar
[
Das, M., Sundell, I. B., Koka, P. S. (2013). Adult mesenchymal stem cells and their potency in the cellbased therapy. J. Stem Cells, 8 (1), 1–16.
]Search in Google Scholar
[
Duijvestein, M., Molendijk, I., Roelofs, H., Vos, A. C., Verhaar, A. P., Reinders, M. E., Fibbe, W. E., Verspaget, H. W., van den Brink, G. R., Wildenberg, M. E., Hommes, D. W. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy, 13 (9), 1066–1073.10.3109/14653249.2011.59737921846292
]Search in Google Scholar
[
Froslie, K. F., Jahnsen, J., Moum, B. A. (2007). Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort. Gastroenterology, 133 (2), 412–422.10.1053/j.gastro.2007.05.05117681162
]Search in Google Scholar
[
Huang, H. R., Zan, H., Lin, Y., Zhong, Y. Q. (2014). Effects of azathioprine and infliximab on mesenchymal stem cells derived from the bone marrow of rats in vitro. Mol. Med. Rep., 9 (3), 1005–1012. DOI: 10.3892/mmr.2014.1905.10.3892/mmr.2014.190524435621
]Search in Google Scholar
[
Kaplan, E. I., Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Amer. Stat. Assoc., 53, 457.10.1080/01621459.1958.10501452
]Search in Google Scholar
[
Knyazev, O., Parfenov, A., Shcherbakov, P., Ruchkina, I., Konoplyanikov, A. (2013). Refractory forms of Crohn's disease cell therapy. Cell. Technol. Biol. Med., 3, 145–152.
]Search in Google Scholar
[
Lichtenstein, G. R., Rutgeerts, P. (2010). Importance of mucosal healing in ulcerative colitis. Inflamm. Bowel Dis., 16, 338–346. DOI: 10.1002/ibd.20997.10.1002/ibd.2099719637362
]Search in Google Scholar
[
Najar, M., Raicevic, G., Fayyad-Kazan, H., Bron, D., Toungouz, M., Lagneaux, L. (2016). Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. Cytotherapy, 18 (2), 160–171. DOI: 10.1016/j.jcyt.2015.10.011.10.1016/j.jcyt.2015.10.01126794710
]Search in Google Scholar
[
Pineton de Chambrun, G., Peyrin-Biroulet, L., Lémann, M., Colombel, J. F. (2010). Clinical implications of mucosal healing for the management of IBD. Nat. Rev. Gastroenterol. Hepatol., 7 (1), 15–29.10.1038/nrgastro.2009.20319949430
]Search in Google Scholar
[
Tsyb, A. F., Konoplyannikov, A. G., Kolesnikov, A. I., Pavlov, V. V. (2004). Preparation and use in medicine, cell cultures of human mesenchymal stem cells of bone marrow cells. Herald of the Russian Academy of Medical Sciences, 59 (9), 71–76.
]Search in Google Scholar
[
Vorobyev, G. I., Khalif, I. L. (2008). Non-specific Inflammatory Bowel Disease. Miklos.
]Search in Google Scholar
[
Watkins, P. E., Warren, B. F., Stephens, S., Ward, P., Foulkes, R. (1997). Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. Gut, 40 (5), 628–633.10.1136/gut.40.5.62810271669203942
]Search in Google Scholar
[
Zallot, C., Peyrin-Biroulet, L. (2013). Deep remission in inflammatory bowel disease: Looking beyond symptoms. Curr. Gastroenterol. Rep., 15 (3), 315. DOI: 10.1007/s11894-013-0315-7.10.1007/s11894-013-0315-723354742
]Search in Google Scholar
